PF4 and COVID-19: Increased levels of platelet aggregates, platelet-derived microparticles, and soluble indicators of platelet activation (P selectin, PF4) suggest the activation of platelets circulating in the bloodstream of COVID-19 patients, while aggregation tests suggest increased platelet reactivity in response to agonists (collagen, thrombin, ADP).